NodThera
PA - Philadelphia
BiotechnologyFocus: NLRP3 inflammasome inhibitors
NodThera is a life sciences company focused on NLRP3 inflammasome inhibitors.
Metabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
NT-0796
Cardiovascular DiseasesClinical Trials (1)
NCT06129409Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease
Phase 1NT-0796
ObesityClinical Trials (1)
NCT07220629Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)
Phase 2NT-0796
Obesity and Type 2 DiabetesClinical Trials (1)
NCT07055516Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2022
Portfolio: 3 clinical trials
Top TAs: Metabolic Diseases
Publications: 16 in PubMed